BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35660018)

  • 1. TET2-BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter.
    Shang Y; Jiang T; Ran L; Hu W; Wu Y; Ye J; Peng Z; Chen L; Wang R
    J Biol Chem; 2022 Jul; 298(7):102095. PubMed ID: 35660018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells.
    Ye J; Liu S; Shang Y; Chen H; Wang R
    Cell Cycle; 2018; 17(8):1014-1025. PubMed ID: 29886802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TET Dioxygenases and DNA Hydroxymethylation in Bisphenols-Stimulated Proliferation of Breast Cancer Cells.
    Li Z; Lyu C; Ren Y; Wang H
    Environ Health Perspect; 2020 Feb; 128(2):27008. PubMed ID: 32105160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer.
    Fischer AD; Veronese Paniagua DA; Swaminathan S; Kashima H; Rubin DC; Madison BB
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G196-G211. PubMed ID: 37310750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.
    Rawłuszko-Wieczorek AA; Siera A; Horbacka K; Horst N; Krokowicz P; Jagodziński PP
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1379-92. PubMed ID: 25557833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achaete scute-like 2 suppresses CDX2 expression and inhibits intestinal neoplastic epithelial cell differentiation.
    Shang Y; Pan Q; Chen L; Ye J; Zhong X; Li X; Meng L; Guo J; Tian Y; He Y; Chen W; Peng Z; Wang R
    Oncotarget; 2015 Oct; 6(31):30993-1006. PubMed ID: 26307678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant upregulation of ASCL2 by promoter demethylation promotes the growth and resistance to 5-fluorouracil of gastric cancer cells.
    Kwon OH; Park JL; Baek SJ; Noh SM; Song KS; Kim SY; Kim YS
    Cancer Sci; 2013 Mar; 104(3):391-7. PubMed ID: 23181270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
    Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
    Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells.
    Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R
    Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
    Wang X; Feng Z; Li Q; Yi B; Xu Q
    Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Basu S; Gavert N; Brabletz T; Ben-Ze'ev A
    Cancer Lett; 2018 Jun; 424():9-18. PubMed ID: 29551399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
    Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
    Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
    Tanaka T; Kojima K; Yokota K; Tanaka Y; Ooizumi Y; Ishii S; Nishizawa N; Yokoi K; Ushiku H; Kikuchi M; Kojo K; Minatani N; Katoh H; Sato T; Nakamura T; Sawanobori M; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 May; 26(5):1401-1411. PubMed ID: 30706227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.
    Tian Y; Pan Q; Shang Y; Zhu R; Ye J; Liu Y; Zhong X; Li S; He Y; Chen L; Zhao J; Chen W; Peng Z; Wang R
    J Biol Chem; 2014 Dec; 289(52):36101-15. PubMed ID: 25371200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
    Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
    J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
    Shao K; Pu W; Zhang J; Guo S; Qian F; Glurich I; Jin Q; Ma Y; Ju S; Zhang Z; Ding W
    Clin Epigenetics; 2021 Apr; 13(1):89. PubMed ID: 33892791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
    Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
    J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.
    Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M
    Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.